Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Advancements In The Cystic Fibrosis Therapeutics Treatment
3.2.2. Increasing Incidence Of Cystic Fibrosis (Cf)
3.2.3. Rise In The R&D Of Novel Cystic Fibrosis Therapeutics
3.3. Key Restraints
3.3.1. Stringent Regulation
3.3.2. Low Awareness Among Developing Economies

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Pestel Analysis
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Route Of Administration
5.1. Inhale
5.2. Oral

6. Market By Drug Class
6.1. Cftr Modulators
6.2. Bronchodilators
6.3. Mucolytic
6.4. Pancreatic Enzyme Supplements

7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Australia & New Zealand
7.3.5. South Korea
7.3.6. Thailand
7.3.7. Indonesia
7.3.8. Vietnam
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East & Africa

8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Agilent Technologies Inc
8.4. Allergan Plc
8.5. F. Hoffmann-La Roche
8.6. Gilead Sciences Inc
8.7. Glaxosmithkline Plc
8.8. Johnson & Johnson
8.9. Mylan N.V
8.10. Novartis Ag
8.11. Perkinelmer
8.12. Pfizer Inc
8.13. Pharmaxis Ltd
8.14. Teva Pharmaceutical Industries Ltd
8.15. Vertex Pharmaceuticals Incorporated



List of Figures


List of Figures

Figure 1: Porter’S Five Forces Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Cystic Fibrosis Therapeutics, By Route Of Administration, In 2019
Figure 6: Global Cystic Fibrosis Therapeutics Market, By Inhale, 2020-2028 (In $ Million)
Figure 7: Global Cystic Fibrosis Therapeutics Market, By Oral, 2020-2028 (In $ Million)
Figure 8: Global Cystic Fibrosis Therapeutics, By Drug Class, In 2019
Figure 9: Global Cystic Fibrosis Therapeutics Market, By Cftr Modulators, 2020-2028 (In $ Million)
Figure 10: Global Cystic Fibrosis Therapeutics Market, By Bronchodilators, 2020-2028 (In $ Million)
Figure 11: Global Cystic Fibrosis Therapeutics Market, By Mucolytic, 2020-2028 (In $ Million)
Figure 12: Global Cystic Fibrosis Therapeutics Market, By Pancreatic Enzyme Supplements, 2020-2028 (In $ Million)
Figure 13: North America Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 14: The United States Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 15: Canada Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 16: Europe Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 17: The United Kingdom Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 18: France Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 19: Germany Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 20: Italy Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 21: Russia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 22: Belgium Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 23: Poland Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 24: Rest Of Europe Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 25: Asia Pacific Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 26: China Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 27: Japan Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 28: India Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 29: Australia & New Zealand Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 30: South Korea Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 31: Thailand Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 32: Indonesia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 33: Vietnam Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 34: Rest Of Asia Pacific Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 35: Rest Of World Cystic Fibrosis Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 36: Latin America Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 37: Middle East & Africa Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)


List of Tables


List of Tables

TABLE 1: MARKET SNAPSHOT - VETERINARY VACCINE
TABLE 2: GLOBAL CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: GLOBAL INHALE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL INHALE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: GLOBAL CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: GLOBAL CFTR MODULATORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: LIST OF CFTR MODULATORS GENERIC AND BRAND NAME
TABLE 12: GLOBAL CFTR MODULATORS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 13: GLOBAL BRONCHODILATORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: LIST OF BRONCHODILATORS GENERIC AND BRAND NAME
TABLE 15: GLOBAL BRONCHODILATORS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: GLOBAL MUCOLYTIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: LIST OF MUCOLYTICS GENERIC AND BRAND NAME
TABLE 18: GLOBAL MUCOLYTIC MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 19: GLOBAL PANCREATIC ENZYME SUPPLEMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL PANCREATIC ENZYME SUPPLEMENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 21: GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 23: NORTH AMERICA CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: NORTH AMERICA CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 25: EUROPE CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 26: EUROPE CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 27: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 28: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 29: REST OF WORLD CYSTIC FIBROSIS THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: REST OF WORLD CYSTIC FIBROSIS THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)